1. 2O Biomarkers of immune switch induced by a novel anti-macrophage antibody (anti-Clever-1 mAb; FP-1305) in MATINS trial patients with advanced solid tumours. (15th December 2019) Authors: Hollmén, M; Virtakoivu, R; Jaakkola, P; Minchom, A; Jalkanen, S; Karvonen, M; Mandelin, J; Koivunen, J; Bono, P Journal: Annals of oncology Issue: Volume 30(2019)Supplement 11 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 420PPhase I/II study of ODM-203, a selective dual FGFR/VEGFR inhibitor, in patients with advanced solid tumours. (23rd October 2018) Authors: Bono, P; Massard, C; Peltola, K; Azaro, A; Italiano, A; Kristeleit, R S; Lassen, U N; Arkenau, H-T; Hakulinen, P; Garratt, C; Ikonen, T; Mustonen, M; Rodon, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 884PReal-world effectiveness of pazopanib in patients with intermediate prognostic risk advanced renal cell carcinoma (PRINCIPAL study). (23rd October 2018) Authors: Procopio, G; Bamias, A; Schmidinger, M; Hawkins, R; Rodriguez Sanchez, A; Vazquez, S; Srihari, N; Kalofonos, H; Bono, P; Pisal, C; Hirschberg, Y; Dezzani, L; Ahmad, Q; Suarez Rodriguez, C; Jonasch, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The MDM2 promoter polymorphism SNP309T→G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck. Issue 9 (1st September 2005) Authors: Alhopuro, P; Ylisaukko-oja, S K; Koskinen, W J; Bono, P; Arola, J; Järvinen, H J; Mecklin, J-P; Atula, T; Kontio, R; Mäkitie, A A; Suominen, S; Leivo, I; Vahteristo, P; Aaltonen, L-M; Aaltonen, L A Journal: Journal of medical genetics Issue: Volume 42:Issue 9(2005) Page Start: 694 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗